NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $349 | -23.0% | 8,401 | +11.5% | 0.00% | 0.0% |
| Q1 2023 | $453 | -20.2% | 7,535 | -2.7% | 0.00% | 0.0% |
| Q4 2022 | $568 | -99.9% | 7,745 | +11.5% | 0.00% | 0.0% |
| Q3 2022 | $527,000 | -1.1% | 6,946 | -9.5% | 0.00% | 0.0% |
| Q2 2022 | $533,000 | -22.8% | 7,674 | -8.0% | 0.00% | -50.0% |
| Q1 2022 | $690,000 | +7.3% | 8,338 | -2.7% | 0.00% | +100.0% |
| Q4 2021 | $643,000 | -0.8% | 8,567 | +53.5% | 0.00% | -50.0% |
| Q3 2021 | $648,000 | -49.1% | 5,582 | -2.8% | 0.00% | -33.3% |
| Q2 2021 | $1,273,000 | +79.0% | 5,741 | +6.7% | 0.00% | +50.0% |
| Q1 2021 | $711,000 | -45.2% | 5,379 | -28.3% | 0.00% | -50.0% |
| Q4 2020 | $1,297,000 | +61.3% | 7,500 | +3.7% | 0.00% | +33.3% |
| Q3 2020 | $804,000 | +86.1% | 7,231 | -0.7% | 0.00% | +50.0% |
| Q2 2020 | $432,000 | +38.5% | 7,285 | +57.0% | 0.00% | +100.0% |
| Q1 2020 | $312,000 | -24.8% | 4,641 | -6.0% | 0.00% | -50.0% |
| Q4 2019 | $415,000 | +70.8% | 4,936 | +51.3% | 0.00% | +100.0% |
| Q3 2019 | $243,000 | – | 3,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |